IBMS Davos Workshops: Bone Biology & Therapeutics
Click here to go to the previous page
Farnesoid X Receptor in Primary Breast Carcinoma: A New Marker To Predict Bone Metastasis? (175)
Program Code:
230-2
Date:
Friday, March 14, 2008
Time:
9:35 AM to 9:40 AM
EST